Key result
Elevated hsCRP links to higher 24-hour systolic blood pressure variability in subacute ischemic stroke.
Why the study?
Determinants of blood pressure variability (BPV) are complex, and whether circulating hsCRP is associated with short-term BPV during the subacute stage of ischemic stroke was unknown.
Is elevated circulating high-sensitivity C-reactive protein (hsCRP) associated with increased short-term 24-hour blood pressure variability during the subacute stage of acute ischemic stroke?
Cross-Sectional (n=325)
Blinded evaluation of lesion distribution and central laboratory hsCRP testing
No
Is elevated circulating high-sensitivity C-reactive protein (hsCRP) associated with increased short-term 24-hour blood pressure variability during the subacute stage of acute ischemic stroke?
Circulating hsCRP is independently and dose-dependently associated with higher 24-hour blood pressure variability during the subacute stage of ischemic stroke, linking systemic inflammation to short-term blood pressure fluctuations.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for inflammation-BPV link in subacute stroke; prospective trials needed before clinical adoption.
The determinants of blood pressure variability (BPV) are complex. We aimed to evaluate whether circulating high-sensitivity C-reactive protein (hsCRP) is associated with short-term BPV during the subacute stage of ischemic stroke. In this observational study, a consecutive series of acute ischemic stroke patients who underwent 24 h ambulator blood pressure monitoring (ABPM) during day 4 to 10 after onset were enrolled. Multivariable linear regression models were constructed to assess relationships between hsCRP and BPV. Among a total of 325 patients analyzed, the mean age was 60 years old and 72% were male. The SD, CV, ARV of 24 h SBP and DBP were more likely to be higher in patients with hsCRP ≥ 2 mg/L, and these predispositions remained unchanged in linear regression analyses after adjusting for possible confounding factors, with a dose-response relationship when patients were additionally categorized into quartiles according to hsCRP levels using the lowest quartile as a reference category. In contrast, similar results were observed for the mean of SBP but not the mean of DBP. These results indicate that hsCRP is dose-dependently associated with short-term BPV during the subacute stage of ischemic stroke. These findings suggested that patients with a higher level of hsCRP tended to have larger blood pressure fluctuations.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2023) conducted a cross-sectional in Subacute stage of acute ischemic stroke (n=325). Elevated circulating high-sensitivity C-reactive protein (hsCRP ≥ 2 mg/L) vs. Lower circulating high-sensitivity C-reactive protein (hsCRP < 2 mg/L) or lowest hsCRP quartile was evaluated on 24-hour systolic blood pressure variability (standard deviation [SD] of 24 h SBP) (β 2.29, 95% CI 1.55-3.04). Elevated hsCRP (≥2 mg/L) was independently associated with higher 24-hour systolic blood pressure variability (SD β 2.29, 95% CI 1.55-3.04) in subacute ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: